Pancreatic Cancer Research

ResearcherChiba UniversityActive in the last 2 years

Jun Kato

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1869-2135; OpenAlex author ID A5102019311. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 6

  1. A Real-world Study on the Prognosis of Patients with Pancreatic Cancer: A Prospective Stationary Survey from 2007-2020. Co-author DOI 10.2169/internalmedicine.6719-25↗
  2. Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center Re… Last author DOI 10.3390/cancers18020194↗
  3. Analysis of circulating cell-free DNA after endoscopic ultrasound-guided fine needle aspiration in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2021.04.001↗
  4. Diverse transitions in diabetes status during the clinical course of patients with resectable pancreatic cancer. Co-author DOI 10.1093/jjco/hyaa136↗
  5. Phase II clinical study of alternate-day oral therapy with S-1 as first-line chemotherapy for locally advanced and metastatic pancreatic cancer. Co-author DOI 10.1007/s00280-013-2323-6↗
  6. Tumor vessel depiction with contrast-enhanced endoscopic ultrasonography predicts efficacy of chemotherapy in pancreatic cancer. Last author DOI 10.1097/mpa.0b013e31827fe94c↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiroshi Ohyama · 3 shared papers, 2021–2026 · strength 0.56
  2. Akinori Abe · 2 shared papers, 2026 · strength 0.46
  3. Shigetsugu Takano · 3 shared papers, 2020–2026 · strength 0.43
  4. Masayuki Ohtsuka · 3 shared papers, 2020–2026 · strength 0.43
  5. Motoyasu Kan · 2 shared papers, 2021–2026 · strength 0.33
  6. Masao Omata · 1 shared paper, 2026 · strength 0.23
  7. Kazuki Watabe · 1 shared paper, 2026 · strength 0.23
  8. Naoya Kato · 2 shared papers, 2020–2021 · strength 0.20
  9. Rintaro Mikata · 2 shared papers, 2020–2021 · strength 0.20
  10. Ayako Shingyoji · 1 shared paper, 2020 · strength 0.10
  11. Hideyuki Yoshitomi · 1 shared paper, 2020 · strength 0.10
  12. Kosho Asano · 1 shared paper, 2021 · strength 0.10
  13. Masahiro Itonaga · 1 shared paper, 2013 · strength 0.03
  14. Yasunobu Yamashita · 1 shared paper, 2013 · strength 0.03
  15. Takeichi Yoshida · 1 shared paper, 2013 · strength 0.03
  16. Kazuo Chijiiwa · 1 shared paper, 2014 · strength 0.03
  17. Taketo Yamaguchi · 1 shared paper, 2014 · strength 0.03
  18. Tetsuhiko Shirasaka · 1 shared paper, 2014 · strength 0.03
  19. Hiroaki Yanagimoto · 1 shared paper, 2014 · strength 0.03
  20. Sohei Satoi · 1 shared paper, 2014 · strength 0.03
  21. Shinichi Egawa · 1 shared paper, 2014 · strength 0.03
  22. Ken‐ichi Okada · 1 shared paper, 2014 · strength 0.03
  23. Hiroki Yamaue · 1 shared paper, 2014 · strength 0.03
  24. Motoki Miyazawa · 1 shared paper, 2014 · strength 0.03
  25. Seiko Hirono · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.